Combination of 5-FU with ChoKα inhibitors as a new alternative therapy in colorectal cancer

被引：0
|
作者：
de la Cueva, Ana [1 ]
Ramirez de Molina, Ana [2 ]
Angeles Ramos, Ma [1 ]
Cebrian, Aranzazu [1 ]
Gomez del Pulgar, Teresa [1 ]
Carlos Lacal, Juan [1 ]
机构：
[1] Inst Invest Biomed Madrid, Madrid, Spain
[2] IMDEA Food Inst, Madrid, Spain
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-3514
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3514
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Optimisation of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of hydroxyurea, leucovorin, 5-FU and cisplatin (HLFP regimen) for metastatic oesophageal cancer
    Taïeb, J
    Artru, P
    Baujat, B
    Mabro, M
    Carola, E
    Maindrault, F
    Tournigand, C
    Krulik, M
    Louvet, C
    de Gramont, A
    EUROPEAN JOURNAL OF CANCER, 2002, 38 (05) : 661 - 666
  • [42] Possibility of rescue for 5-FU-resistant gastric cancer by combination administration of 5-FU with CDHP
    Sasaki, E
    Tominaga, K
    Kuwamura, H
    Shiba, M
    Watanabe, T
    Fujiwara, Y
    Oshitani, N
    Higuchi, K
    Matsumoto, T
    Arakawa, T
    GASTROENTEROLOGY, 2003, 124 (04) : A555 - A555
  • [43] TOPICAL 5-FU - NEW APPROACH TO SKIN CANCER
    WILLIAMS, AC
    ANNALS OF SURGERY, 1971, 173 (06) : 864 - &
  • [44] 5-FU for cervical cancer
    不详
    AIDS PATIENT CARE AND STDS, 2000, 14 (03) : 173 - 173
  • [45] Suramin in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in metastatic colorectal cancer patients resistant to 5-FU+LV-based chemotherapy
    Falcone, A
    Pfanner, E
    Brunetti, I
    Allegrini, G
    Lencioni, M
    Galli, C
    Masi, G
    Danesi, D
    Antonuzzo, A
    Del Tacca, M
    Conte, PF
    TUMORI, 1998, 84 (06) : 666 - 668
  • [46] The role of GLI1 for 5-Fu resistance in colorectal cancer
    Zhang, Lining
    Song, Ruolan
    Gu, Dongsheng
    Zhang, Xiaoli
    Yu, Beiqin
    Liu, Bingya
    Xie, Jingwu
    CELL AND BIOSCIENCE, 2017, 7
  • [47] The role of GLI1 for 5-Fu resistance in colorectal cancer
    Lining Zhang
    Ruolan Song
    Dongsheng Gu
    Xiaoli Zhang
    Beiqin Yu
    Bingya Liu
    Jingwu Xie
    Cell & Bioscience, 7
  • [48] Safety and Efficacy of mFOLFOX6+Panitumumab Combination Therapy and 5-FU/LV + Panitumumab Combination Therapy in Patients with Chemotherapy-Naive Metastatic Colorectal Cancer (SAPPHIRE)
    Nagata, N.
    Mishima, H.
    Kurosawa, S.
    Oba, K.
    Sakamoto, J.
    ANNALS OF ONCOLOGY, 2016, 27 : 80 - 80
  • [49] Safety and efficacy of mFOLFOX6+panitumumab combination therapy and 5-FU/LV + panitumumab combination therapy in patients with chemotherapy-naive metastatic colorectal cancer (SAPPHIRE)
    Nagata, N.
    Mishima, H.
    Kurosawa, S.
    Oba, K.
    Sakamoto, J.
    ANNALS OF ONCOLOGY, 2015, 26 : 68 - 68
  • [50] Oxaliplatin with 5-FU or as a single agent in advanced/metastatic colorectal cancer
    Mitchell, EP
    ONCOLOGY-NEW YORK, 2000, 14 (12): : 30 - 32
12345